# The ONE Study UK Treg Trial

> **NCT02129881** · PHASE1,PHASE2 · COMPLETED · sponsor: **Guy's and St Thomas' NHS Foundation Trust** · enrollment: 15 (actual)

## Conditions studied

- End-stage Renal Failure

## Interventions

- **BIOLOGICAL:** Autologous regulatory T Cell Product

## Key facts

- **NCT ID:** NCT02129881
- **Lead sponsor:** Guy's and St Thomas' NHS Foundation Trust
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-04
- **Primary completion:** 2017-03-23
- **Final completion:** 2017-03-23
- **Target enrollment:** 15 (ACTUAL)
- **Last updated:** 2019-01-25

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02129881

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02129881, "The ONE Study UK Treg Trial". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02129881. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*